H3K27me3 methylation of the ODZ4 promoter suppresses miR-708-5p expression in both chronic lymphoblastic leukemia (CLL) and breast cancer, highlighting multiple layers of regulation in suppressing miR-708-5p expression [53, 54]. Here, TENM4 is linked to B-cell chronic lymphocytic leukemia.